🔎 Trials Near Me

ホーム › 過体重 › フロリダ州 › Orlando

Orlando、FLにおける過体重の臨床試験

Orlandoとその周辺地域(約30マイル以内)の拠点で、過体重に関する27件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。

公式研究テキスト(英語)

ここで研究参加者を募集していますか? このページの上部に表示できます — 30日間 $99 →

Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients

被験者募集中
  • Orlando Health, Inc., Orlando
21歳〜65歳 · 全性別 · 2026/10/01更新 · NCT07090005

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

被験者募集中第2相
  • Charter Research - Winter Park /ID# 281968, Orlando
  • Florida Institute For Clinical Research /ID# 282739, Orlando
18歳〜75歳 · 全性別 · 2026/10/01更新 · NCT07752979

A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide

被験者募集中第1相健康なボランティア歓迎
  • Kailera Clinical Site, Orlando
18歳〜85歳 · 全性別 · 2026/10/01更新 · NCT07793929

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

被験者募集中第3相
  • Florida Institute for Clinical Research, LLC, Orlando
18歳以上 · 全性別 · 2026/09/30更新 · NCT07533175

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

被験者募集中第2相
  • Clinical Site Partners, LLC DBA Flourish Research, Winter Park · 5マイル先
  • K2 Medical Research Maitland LLC, Main Office, Maitland · 6マイル先
18歳以上 · 全性別 · 2026/09/29更新 · NCT07685808

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

被験者募集中第3相
  • Clinical Neuroscience Solution, Orlando
  • Florida Institute for Clinical Research, LLC, Orlando
18歳以上 · 全性別 · 2026/09/28更新 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

被験者募集中第3相
  • Florida Inst For Clin Res LLC, Orlando
18歳以上 · 全性別 · 2026/09/28更新 · NCT07668414

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

被験者募集中第2相
  • Clinical Neuroscience Solutions, Orlando
18歳〜75歳 · 全性別 · 2026/09/28更新 · NCT07837973

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

被験者募集中第3相
  • Headlands Research Orlando, Orlando
18歳以上 · 全性別 · 2026/09/28更新 · NCT07794579

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

被験者募集中第3相
  • Florida Hospital- Center for Pediatric Research, Orlando
  • Nemours Children's Health, Orlando
6歳〜17歳 · 全性別 · 2026/09/24更新 · NCT06672549

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

被験者募集中第3相
  • Orlando Health, Orlando
  • Digestive and Liver Center of Florida, Orlando
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT06937099

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

被験者募集中第3相
  • Orlando Health, Orlando
  • Digestive and Liver Center of Florida, Orlando
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT06937086

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

被験者募集中第3相
  • West Orange Endocrinology, Ocoee · 10マイル先
45歳〜99歳 · 全性別 · 2026/09/22更新 · NCT07037433

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

被験者募集中第2相
  • Charter Research - Winter Park, Orlando
18歳〜75歳 · 全性別 · 2026/09/22更新 · NCT07589608

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

被験者募集中第3相
  • Conquest Research, Winter Park · 5マイル先
18歳以上 · 全性別 · 2026/09/22更新 · NCT07353931

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

被験者募集中第3相
  • Clinical Site Partners, LLC dba Flourish Research, Winter Park · 5マイル先
18歳以上 · 全性別 · 2026/09/22更新 · NCT07282600

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

被験者募集中第3相
  • Research Site, Ocoee · 10マイル先
18歳以上 · 全性別 · 2026/09/22更新 · NCT07784270

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

被験者募集中第3相
  • AURORA-1 Clinical Site, Winter Park · 5マイル先
18歳以上 · 全性別 · 2026/09/16更新 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

被験者募集中第3相
  • AURORA-2 Clinical Site, Winter Park · 5マイル先
18歳以上 · 全性別 · 2026/09/16更新 · NCT07743450

Feasibility and Acceptability of a Pediatric Referral to Summer Day Camps to Treat Obesity in Children From Low-Income Households

被験者募集中
  • University of Central Florida, Orlando
5歳〜11歳 · 全性別 · 2026/09/14更新 · NCT07464015

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

被験者募集中第3相健康なボランティア歓迎
  • ACCOMPLISH-2 Research Site, Ocoee · 10マイル先
18歳〜79歳 · 全性別 · 2026/09/11更新 · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

被験者募集中第2相
  • Charter Research - Winter Park, Orlando
18歳〜75歳 · 全性別 · 2026/09/08更新 · NCT06143956

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

被験者募集中第3相
  • Clinical Neuroscience Solutions - Orlando, Orlando
  • Combined Research Orlando Phase I IV, Orlando
  • Florida Institute for Clinical Research, Orlando
18歳〜99歳 · 全性別 · 2026/09/03更新 · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

被験者募集中第3相
  • Florida Institute for Clinical Research, Orlando
  • Conquest Research - Winter Park, Winter Park · 5マイル先
18歳〜99歳 · 全性別 · 2026/09/03更新 · NCT07684144

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

被験者募集中第3相
  • Kailera Clinical Site, Orlando
  • Kailera Clinical Site, Orlando
18歳以上 · 全性別 · 2026/09/03更新 · NCT07284901

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

被験者募集中第3相
  • Clinical Neuroscience Solutions, Orlando
  • Florida Institute for Clinical Research, Orlando
18歳〜99歳 · 全性別 · 2026/08/27更新 · NCT07575399

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

被験者募集中第3相
  • ACCOMPLISH-1 Research Site, Ocoee · 10マイル先
18歳〜79歳 · 全性別 · 2026/08/10更新 · NCT07654361

他の都市における過体重の試験

Orlandoにおける他の研究

ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。